Income level doesn't substantially impact CPAP use

October 30, 2015
Income level doesn't substantially impact CPAP use

(HealthDay)—Among patients with severe obstructive sleep apnea (OSA), patient neighborhood income level is not significantly associated with purchase of continuous positive airway pressure (CPAP) device, and the overall rate of uptake remains low, according to a study published online Oct. 16 in the Annals of the American Thoracic Society.

Tetyana Kendzerska, M.D., Ph.D., from the University of Toronto, and colleagues examined the correlation between patient neighborhood income level and the purchase of a CPAP device under a cost-sharing health care insurance system. Data were included for all adults who underwent a first diagnostic sleep study between 2004 and 2010. Purchase of CPAP equipment was determined using patient data linked to provincial health administrative data.

The researchers found that 58 percent of the 695 participants with severe OSA and purchased a CPAP device. The cumulative incidence of CPAP acceptance at six months was 43 and 52 percent for individuals in a low income neighborhood and combined higher income neighborhoods, respectively (P = 0.05). Living in higher income versus the lowest neighborhood correlated with an increased chance of accepting CPAP, after adjustment for sex and age (hazard ratio, 1.27; P = 0.07).

"From the physician perspective, the CPAP acceptance rate may be improved by focusing on non-financial obstacles such as providing early education and support in patients with less severe disease to develop beliefs and expectations about OSA and CPAP," the authors write.

Explore further: Sleep apnea treatment may reverse unhealthy brain changes

More information: Full Text (subscription or payment may be required)

Related Stories

Sleep apnea treatment may reverse unhealthy brain changes

September 15, 2015
(HealthDay)—Sleep apnea treatment may reverse changes in brain stem activity associated with increased risk of heart disease, a new study suggests.

2.5 hours of patient/therapist contact time increases CPAP use

October 22, 2012
Although continuous positive airway pressure (CPAP) is often used as therapy for obstructive sleep apnea (OSA), patient compliance with CPAP remains an issue.

Study shows CPAP use for sleep apnea does not negatively impact sexual quality of life

October 21, 2014
Patients who use a continuous positive airway pressure (CPAP) device to treat obstructive sleep apnea (OSA) often believe that it makes them less sexually attractive, according to researchers at Rosalind Franklin University. ...

CPAP therapy reduces symptoms of depression in adults with sleep apnea

September 22, 2015
A new study shows that depressive symptoms are extremely common in people who have obstructive sleep apnea, and these symptoms improve significantly when sleep apnea is treated with continuous positive airway pressure therapy.

Cranial nerve stimulation shows promise as sleep apnea tx

October 1, 2015
(HealthDay)—An implanted cranial nerve stimulation device might improve sleep patterns and quality of life for patients with obstructive sleep apnea (OSA), according to findings presented this week at the annual meeting ...

Sleep apnea therapy treats patients through upper airway stimulation

June 30, 2015
A state-of-the-art implant designed to treat obstructive sleep apnea (OSA) is now being offered at NewYork-Presbyterian/Weill Cornell Medical Center. The device is the first of its kind approved by the U.S. Food and Drug ...

Recommended for you

Synthetic cannabinoid reduces sleep apnea

November 29, 2017
A synthetic version of a molecule found in the cannabis plant was safe and effective in treating obstructive sleep apnea in the first large, multi-site study of a drug for the sleep disorder funded by the National Institutes ...

Sleeping through the snoring: Researchers identify neurons that rouse the brain to breathe

November 2, 2017
A common and potentially serious sleep disorder, obstructive sleep apnea affects at least one quarter of U.S. adults and is linked to increased risk of diabetes, obesity and cardiovascular disease. In a paper published today ...

Remede system approved for sleep apnea

October 9, 2017
(HealthDay)—The Remede sleep system, an implanted device that treats central sleep apnea by activating a nerve that sends signals to the diaphragm to stimulate breathing, has been approved by the U.S. Food and Drug Administration.

Inflammation may precede sleep apnea, could be treatment target

September 1, 2017
Inflammation is traditionally thought of as a symptom of sleep apnea, but it might actually precede the disorder, potentially opening the door for new ways to treat and predict sleep apnea, according to researchers.

More evidence: Untreated sleep apnea shown to raise metabolic and cardiovascular stress

August 31, 2017
Sleep apnea, left untreated for even a few days, can increase blood sugar and fat levels, stress hormones and blood pressure, according to a new study of sleeping subjects. A report of the study's findings, published in the ...

Sleep patterns contribute to racial differences in disease risk

August 18, 2017
Poor sleep patterns could explain, in part, the differences in the risk of cardiometabolic disease between African-Americans and European-Americans, according to a new study published in Proceedings of the National Academy ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.